Explore the latest in neuro-oncology, including advances in diagnosis and management of glial tumors, CNS lymphomas, and CNS metastases.
This Viewpoint discusses the challenges and opportunities of including patients with glioma in clinical trials.
This review summarizes current evidence regarding diagnosis and treatment of primary malignant brain tumors in adults.
This cohort study evaluates the association of overall social vulnerability and specific social determinants of health with disparities in head and neck cancer care and prognosis among children and adolescents in the United States.
This systematic review examines the proportion of patients with leptomeningeal disease included in phase 3 randomized clinical trials for patients with metastatic breast cancer, lung cancer, and melanoma.
This randomized clinical trial compares the use of gefitinib plus chemotherapy with gefitinib monotherapy in patients with untreated EGFR-mutant non–small cell lung cancer brain metastases.
This subgroup analysis of a randomized clinical trial investigates whether tucatinib in combination with trastuzumab and capecitabine provides survival and intracranial benefits for patients with ERBB2-positive metastatic breast cancer and brain metastases.
This phase 2 randomized clinical trial evaluates the effect of β-glucan administered during vaccine priming on antibody titer and seroconversion rates at a large cancer center in children with high-risk neuroblastoma.
This randomized clinical trial evaluates the efficacy of the combination of temozolomide with interferon alfa in patients with newly diagnosed high-grade glioma.
This nonrandomized controlled trial investigates whether adding autologous tumor lysate-loaded dendritic cell vaccine (DCVax-L) to standard of care extends survival among patients with newly diagnosed or recurrent glioblastoma.
This case report describes a patient with anti–leucine-rich glioma-inactivated 1 (LGI1)–associated hyperexcitability syndrome associated with myopathy.
This case-control study evaluates meningioma risk following radiotherapy and chemotherapy and identifies possible factors associated with modifying radiation-associated risk in survivors of childhood cancer.
This secondary analysis examines the long-term association of whole-brain radiotherapy and stereotactic radiosurgery with quality of life and cognition outcomes for patients with limited brain metastasis following surgical resection.
This randomized clinical trial assesses the safety of withholding perioperative hydrocortisone during the perioperative period of pituitary adenoma surgery for patients with an intact hypothalamus-pituitary-adrenal axis.
This cohort study assesses the prevalence and types of visual symptoms and abnormal ophthalmological findings in Dutch youths with a newly diagnosed brain tumor.
This narrative review discusses the implications of the 2021 updates to the World Health Organization (WHO) central nervous system (CNS) tumor classification relative to adult-type glioma diagnosis, prognosis, and treatment.
This cohort study examines clinician-perceived freeform report meaning and discordance with nuclear medicine interpretation using the modified Deauville score.
This Viewpoint discusses the identification and treatment of brain metastasis as a distinct disease and its management with a multidisciplinary approach to improve patient outcomes.
This cohort study characterizes the clinical and genomic features of patients with brain metastasis from gastroesophageal adenocarcinoma and evaluates the associations of surgical resection and radiotherapy use with survival.
This systematic review and meta-analysis describes postoperative outcomes associated with gross total resection, subtotal resection, and biopsy in children with high-grade gliomas.
Customize your JAMA Network experience by selecting one or more topics from the list below.